Table 2 Baseline characteristics in relation to incident ischemic stroke and incident CE status in the MDC-CV (n = 4795)
From: Comparison of risk factors for ischemic stroke and coronary events in a population-based cohort
Population without CE or ischemic stroke (n = 3935) | With only incident ischemic stroke (n = 320) | With only incident CE (n = 447) | With both CE and ischemic stroke (n = 93) | p value | |
|---|---|---|---|---|---|
Age (years) | 57.14 (5.95) | 59.93 (5.38) | 59.64 (5.44) | 61.40 (4.44) | < 0.001 |
Sex (men) n % | 1450 (36.8) | 147 (45.9) | 266 (59.5) | 51 (54.8) | < 0.001 |
Waist (cm) | 82.47 (12.52) | 85.91 (12.76) | 88.44 (13.34) | 89.23 (12.48) | < 0.001 |
Diabetes n % | 120 (3) | 30 (9.4) | 42 (9.4) | 12 (12.9) | < 0.001 |
Smoking n % | 1003 (25.5) | 97 (30.3) | 137 (30.6) | 32 (34.4) | 0.002 |
Systolic blood pressure (mmHg) | 139.74 (18.63) | 146.57 (19.19) | 148.06 (18.55) | 154.13 (20.21) | < 0.001 |
Anti-hypertensive medication n % | 538 (13.7) | 76 (23.8) | 97 (21.7) | 31 (33.3) | < 0.001 |
LDL cholesterol (mmol/L) | 4.14 (0.99) | 4.21 (1.07) | 4.30 (0.92) | 4.39 (1.01) | 0.001 |
Orosomucoid (g/L) 53 missing | 0.70 (± 0.21) | 0.73 (± 0.22) | 0.73 (± 0.23) | 0.79 (± 0.28) | < 0.001 |
Haptoglobin (g/L) 431 missing | 1.30 (± 0.54) | 1.37 (± 0.58) | 1.38 (± 0.59) | 1.42 (± 0.62) | 0.002 |
Alpha1-antitrypsin (g/L) 80 missing | 1.20 (± 0.27) | 1.20 (± 0.30) | 1.25 (± 0.29) | 1.32 (± 0.32) | < 0.001 |
Ceruloplasmin (g/L) 288 missing | 0.51 (± 0.12) | 0.51 (± 0.13) | 0.51 (± 0.11) | 0.52 (± 0.11) | 0.455 |
C3a (g/L) 5 missing | 1.48 (1.30–1.70) | 1.52 (1.36–1.72) | 1.55 (1.36–1.76) | 1.54 (1.40–1.81) | 0.002 |
CRPa (mg/L) 161 missing | 1.30 (0.60–2.60) | 1.50 (0.70–3.40) | 1.60 (0.80–3.30) | 1.85 (0.98–3.33) | < 0.001 |
suPARa (ng/mL) 126 missing | 2.79 (2.40–3.34) | 3.04 (2.52–3.65) | 2.88 (2.48–3.63) | 3.13 (2.69–3.57) | < 0.001 |